AAOS Now, November 2026
-
For younger adults with hip fractures, THA may lower complications — but treatment remains individualized
When a “young” hip fracture patient is in their 40s, the treatment decision becomes anything but straightforward.
-
Circulating tumor DNA shows promise for soft-tissue sarcoma surveillance
A personalized blood test that detects fragments of tumor DNA may offer orthopaedic oncologists another tool for monitoring patients with soft-tissue sarcoma, according to findings from a small pilot study presented at the 2026 AAOS Annual Meeting.
-
Knee arthrodiastasis may preserve motion after infected TKA
For patients with persistent infection after total knee arthroplasty, knee arthrodiastasis may offer an alternative to arthrodesis that preserves limited motion.
-
AJRR marks major research milestones
Data from the American Joint Replacement Registry (AJRR), with analysis by the Registry Analytics Institute (RAI), helps researchers gain key insights into the value and potential of hip and knee arthroplasty procedures.